Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > 12th oct?

<< Previous

Bullboard Posts

Next >>

Comment by Chritterson Oct 11, 2020 9:39am

237 Views

Post# 31702230

RE:12th oct?

I doubt next week either, I emailed Robert and the 2019 filings are done still waiting to send in the 2020 Filings, so he hasnt even applied to TSX to get this unhalted, He has to file everything first so hey we have been stuck waiting 3 Months, whats another 2 weeks haha.

011Peking wrote:
Will this lovely stock get back on the market tomorrow?!

Been waiting s freakin long now for this thing to pop!!!

But im not and tiu shouldn't sell! Ever!